Cambridge Nutritional Sciences (CNS) 1H26 results to end September 2025 reflect what has been a challenging period for the company. 1H26 revenues of £3.9m were down c7% YoY from £4.1m, largely driven by a slowdown in customer orders across key territories, particularly in Europe which has faced exposure to increased competition. Despite these headwinds, further efficiencies in production processes saw gross margins improve by 233bps to 67.7% (1H25: 65.4%) meaning the group managed to deliver an ....
